Finance

Beta
Lists
JSPR:NASDAQ
Jasper Therapeutics Inc
$0.47
-5.01%
(-0.025) 1D
$0.46
-1.71% (-0.0080)
After hours
Closed: Jun 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JSPR...
Open
$0.50
High
$0.51
Low
$0.46
Mkt. cap
13.17M
Avg. vol.
488.87K
Volume
570.40K
52-wk high
$7.19
52-wk low
$0.43
EPS
-$3.23
Beta
3.00
Shares outstanding
28.00M
No. of employees
22
Open
$0.50
High
$0.51
Low
$0.46
Mkt. cap
13.17M
Avg. vol.
488.87K
Volume
570.40K
52-wk high
$7.19
52-wk low
$0.43
EPS
-$3.23
Beta
3.00
Shares outstanding
28.00M
No. of employees
22
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to JSPR in the past 3 months
Buy
Buy
2
Hold
4
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for JSPR in the last 3 months.
Highest
Current $0.47
$20.00 (+4,173.50%)
Average
$7.88 (+1,583.76%)
Lowest
$1.50 (+220.51%)
News stories
From sources across the web
About Jasper Therapeutics Inc
CEO-
Employees22
Founded2018
HeadquartersRedwood City, California, United States
SectorBiotechnology
Websitejaspertx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
21.20M
13.10M
10.85M
5.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.88M
4.26M
4.49M
5.14M
Operating expense
27.08M
17.36M
15.35M
10.95M
Total operating expenses
27.08M
17.36M
15.35M
10.95M
Operating income
-27.08M
-17.36M
-15.35M
-10.95M
Other non operating income
-84.00K
88.00K
6.40M
9.61M
EBT including unusual items
-26.72M
-18.74M
-9.10M
-1.17M
EBT excluding unusual items
-26.72M
-16.93M
-8.61M
-1.17M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.72M
-18.74M
-9.10M
-1.17M
Net profit margin
-
-
-
-
Earnings per share
-1.74
-1.25
-0.54
-0.38
Interest and investment income
437.00K
342.00K
338.00K
164.00K
Interest expense
-
-
-
-
Net interest expenses
437.00K
342.00K
338.00K
164.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.82M
-17.13M
-15.06M
-10.93M
Gain or loss from assets sale
2.00K
-2.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer